Experiences in Sensor-Augmented Pump Therapy in Families with two Children with Type 1 diabetes: A Qualitative Study
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Background Caring for a child with type 1 diabetes is a tremendous challenge for a family. The aim of the study was to explore the experiences of transition to sensor-augmented pump therapy (SAP) in families with 2 affected children and the internal and external conditions which potentially impede or facilitate the adjustment process. Methods 5 families (9 parents, 8 children and adolescents) who used the SAP technology for 6 months were interviewed to describe their experiences. The interviews were analysed using thematic content analysis. Results Qualitative analysis of the transcribed interviews revealed that the adaptation process to SAP consisted of several phases and differed among families. There were benefits as well as hassles of using SAP with regard to managing the diabetes, and psychosocial issues: school and peer relations, as well as family relations. While parents clearly regarded the improved metabolic control and hypoglycaemic safety as the most important benefits of SAP, the hassles reported as most important covered a wide range, from technical problems of the system to family conflicts. On the whole, families rated the experience of using SAP as a positive one, with most recommending SAP to other families as long as they were willing to come to terms with the technology and commit to the work and time involved. Conclusion Sensor-augmented pump therapy can be extremely beneficial and a resource for families who care for more than one child with diabetes. During the adaptation process there is a great need of education and frequent follow-up e. g., by telemedical support.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AID systems are recommended for all persons with T1D, since their use has been shown to increase TIR, especially in the overnight period, without causing an increased risk of hypoglycemia.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1183]
In the citing paper
“Pivotal trials for 3 HCL systems have shown success in improving TIR and reducing hypoglycemia both in the pediatric and adult age group.1182–1184”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1183]
In the citing paper
“CGM used completely independently of insulin pump therapy (“open-loop”) or in conjunction with an SAP system (where insulin can be interrupted before or when glucose drops below a hypoglycemic threshold) has been shown to benefit glycemic control for all age groups with T1D.153,1182–1184”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1183]
Citations
Cites
Streisand, R., Swift, E., Wickmark, T., Chen, R., & Holmes, C. S. (2005) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsi076 · Cited by 343
Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0889 · Cited by 249
Mauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., Tansey, M., White, N. H., Weinzimer, S. A., Tamborlane, W., Kollman, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1746 · Cited by 204
Pickup, J. C., Ford Holloway, M., & Samsi, K. (2015) · Diabetes Care · doi:10.2337/dc14-1855 · Cited by 189
Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes
Tansey, M., Laffel, L., Cheng, J., Beck, R., Coffey, J., Huang, E., Kollman, C., Lawrence, J., Lee, J., Ruedy, K., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03368.x · Cited by 125
Use of continuous glucose monitoring in children and adolescents *
Phillip, M., Danne, T., Shalitin, S., Buckingham, B. A., Laffel, L. M., Tamborlane, W. V., Battelino, T., & Participants, F. T. C. F. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00849.x · Cited by 122
Quality-of-Life Measures in Children and Adults With Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc10-0331 · Cited by 101
Tsalikian, E., Fox, L., Weinzimer, S., Buckingham, B., White, N. H., Beck, R., Kollman, C., Xing, D., Ruedy, K., & Diabetes Research in Children Network (DirecNet) Study Group (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00837.x · Cited by 83
Real-Life Utilization of Real-Time Continuous Glucose Monitoring: The Complete Picture
Ramchandani, N., Arya, S., Ten, S., & Bhandari, S. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500407 · Cited by 82
Markowitz, J. T., Pratt, K., Aggarwal, J., Volkening, L. K., & Laffel, L. M. B. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0201 · Cited by 80
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
von Sengbusch, S., Dördelmann, J., Lemke, S., Lange, K., Hiort, O., Katalinic, A., & Frielitz, F. (2020) · Diabetic Medicine · doi:10.1111/dme.14410 · Cited by 35
Frielitz, F., Müller–Godeffroy, E., Hübner, J., Eisemann, N., Dördelmann, J., Menrath, I., Katalinic, A., Hiort, O., & von Sengbusch, S. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819861991 · Cited by 37
“However, this new technology requires a high level of skill in dealing with a variety of information that directly affects insulin therapy.(1) To get the greatest benefit from CGM data, patients and caregivers may need more frequent contact with the diabetes team to learn how to use the new technology to its full pote…”
BackgroundSelf-citationPsychosocial Aspects of Diabetes Technology Use
Papadakis, J. L., Anderson, L. M., Garza, K. P., Feldman, M. A., Shapiro, J. B., Evans, M. A., Thompson, L. G., & Weissberg-Benchell, J. A. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.004 · Cited by 30
Luo, X., Pan, J., Lu, H., & Li, X. (2021) · Nursing Open · doi:10.1002/nop2.971 · Cited by 5
Metadata
- Authors
- Bomba, F., Müller-Godeffroy, E., & von Sengbusch, S.
- Affiliations
- University of Lübeck (DE)
- Department of Paediatrics and Adolescent Medicine, University of Luebeck, Luebeck, Germany
- Corresponding author
- Bomba, Franziska
- ORCID
- Bomba, Franziska
- Venue
- Experimental and Clinical Endocrinology & Diabetes
- Publisher
- Georg Thieme Verlag KG
- Published
- 2017-07-27
- Volume
- 126
- Issue
- 03
- Pages
- 162-167
- ISSN
- 0947-7349 (ISSN-L)
- 1439-3646
- OpenAlex
- W2741419584
- Cited by
- 12
- References
- 23
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 2
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Damp Stiftung
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- sensor-augmented pump therapy, type 1 diabetes, family caregivers, parental experiences, adolescents, hypoglycemia, metabolic control, family conflict, diabetes education
- MeSH terms
- Adolescent, Adult, Child, Diabetes Mellitus, Type 1, Family, Female, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Patient Acceptance of Health Care, Blood Glucose Self-Monitoring, Patient Satisfaction, Telemedicine, Qualitative Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Experiences in Sensor-Augmented Pump Therapy in Families with two Children with Type 1 diabetes: A Qualitative Study. https://app.cochat.ai/papers/10.1055/s-0043-110479
- The paper
- Bomba, F., Müller-Godeffroy, E., & von Sengbusch, S. (2018). Experiences in Sensor-Augmented Pump Therapy in Families with two Children with Type 1 diabetes: A Qualitative Study. Experimental and Clinical Endocrinology & Diabetes. https://doi.org/10.1055/s-0043-110479
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.